All News

Ophthalmologist Holocaust survivor shares his story

In observance of International Holocaust Remembrance Day, January 27, 2021, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.

Chemical in hand sanitizers can injure children’s eyes

Amid the COVID-19 pandemic, the use of hand sanitizers has increased. However, when they are used improperly, hand sanitizers can damage the eyes. Ophthalmologists are now treating young patients who got the liquid in their eyes.

Betamethasone 0.2% gets positive marks in Phase II trial for treatment of post-cataract surgery pain, inflammation

The investigational therapy met all primary endpoints of absence of inflammation at both Day 8 and Day 15 for the treatment of pain and inflammation following cataract surgery.

The MGD patient journey: maintenance over time

January 21, 2021

Cynthia Matossian, MD, FACS, ABES, continues her discussion on MGD treatment by explaining why it's important for patients to understand that MGD and dry eye are lifelong, chronic conditions requiring regular maintenance and monitoring.

Neurophth and AAVnerGene partner on AAV capsids for next-gen ophthalmic gene therapy

January 19, 2021

Neurophth Therapeutics, Inc (Neurophth) and AAVnerGene Inc have announced the launch of a strategic partnership that will grant Neurophth global rights to mutually select adeno-associated virus (AAV) capsids for the creation of the next-generation ophthalmic gene therapy.

Enrollment completed for first Phase 3 study of perfluorohexyloctane

January 19, 2021

Bausch + Lomb has enrolled 599 participants in the first of two Phase 3 studies evaluating perfluorohexyloctane as a first-in-class investigational drug to treat the signs and symptoms of dry eye disease associated with meibomian gland dysfunction.

As COVID-19 focuses attention on vaccine, medication shortages loom

January 14, 2021

Amid ramped up production of vaccines, CARES Act gives FDA power to head off potential drug shortfalls. Prevent Blindness is urging the FDA to use its authority to ensure TED treatment drug supply isn’t interrupted.